TRENTON, N.J. (AP) — Pfizer Inc. is dramatically stepping up sales efforts in emerging markets, overhauling U.S. business operations and slashing more costs ahead of the 2011 patent loss for cholesterol blockbuster Lipitor, its head of pharmaceutical operations said Monday.
